Boulding Mark Elliott bought PTCT
October 9, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 192 shares of PTC Therapeutics, Inc. at $39.42 per share, a transaction worth $7.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
192
Price
$39.42
Total value
$7.6K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 9, 2026
Filing dateOctober 13, 2026
Shares owned after105,464
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.